Abvc Biopharma (ABVC) Receivables - Net (2018 - 2024)
Abvc Biopharma (ABVC) has disclosed Receivables - Net for 8 consecutive years, with $1529.0 as the latest value for Q3 2024.
- For the quarter ending Q3 2024, Receivables - Net changed 0.07% year-over-year to $1529.0, compared with a TTM value of $1529.0 through Sep 2024, changed 0.07%, and an annual FY2023 reading of $1530.0, down 99.8% over the prior year.
- Receivables - Net was $1529.0 for Q3 2024 at Abvc Biopharma, roughly flat from $1530.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $839983.0 in Q4 2023 and bottomed at $1529.0 in Q3 2024.
- Average Receivables - Net over 5 years is $225176.7, with a median of $159712.0 recorded in 2020.
- The sharpest move saw Receivables - Net soared 256.14% in 2021, then crashed 98.77% in 2024.
- Year by year, Receivables - Net stood at $159712.0 in 2020, then surged by 75.75% to $280692.0 in 2021, then soared by 169.81% to $757343.0 in 2022, then rose by 10.91% to $839983.0 in 2023, then plummeted by 99.82% to $1529.0 in 2024.
- Business Quant data shows Receivables - Net for ABVC at $1529.0 in Q3 2024, $1530.0 in Q2 2024, and $1530.0 in Q1 2024.